Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension.

Literature DB >> 18641026

Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension.

Precious P Landburg, Tom Teerlink, Eduard J van Beers, Frits A J Muskiet, Mies C Kappers-Klunne, Joost W J van Esser, Melvin R Mac Gillavry, Bart J Biemond, Dees P M Brandjes, Ashley J Duits, John-John Schnog.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2008 PMID： 18641026 DOI： 10.3324/haematol.12928

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Pulmonary Hypertension Subtypes and Mortality in CKD.

Authors: Daniel L Edmonston; Kishan S Parikh; Sudarshan Rajagopal; Linda K Shaw; Dennis Abraham; Alexander Grabner; Matthew A Sparks; Myles Wolf
Journal: Am J Kidney Dis Date: 2019-11-12 Impact factor: 8.860

2. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.

Authors: Prabhakar Deonikar; Mahendra Kavdia
Journal: J Appl Physiol (1985) Date: 2012-01-05

3. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors: Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal: Am J Hematol Date: 2009-09 Impact factor: 10.047

4. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.

Authors: Mohammad S Eram; Yudao Shen; Magdalena Szewczyk; Hong Wu; Guillermo Senisterra; Fengling Li; Kyle V Butler; H Ümit Kaniskan; Brandon A Speed; Carlo Dela Seña; Aiping Dong; Hong Zeng; Matthieu Schapira; Peter J Brown; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy; Jing Liu; Masoud Vedadi; Jian Jin
Journal: ACS Chem Biol Date: 2015-12-08 Impact factor: 5.100

5. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.

Authors: Gregory J Kato; Zeneng Wang; Roberto F Machado; William C Blackwelder; James G Taylor; Stanley L Hazen
Journal: Br J Haematol Date: 2008-03-17 Impact factor: 6.998

Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension.

1. Pulmonary Hypertension Subtypes and Mortality in CKD.

2. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.

3. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

4. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.

5. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.

Review 6. Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders.

Review 7. From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases.

8. Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks.

Review 9. Protein arginine methylation of non-histone proteins and its role in diseases.

10. Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction.